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1. Introduction 
The fragment obtained by incubation of rabbit 
IgG with soluble plasmin, Facb, lacks the C-terminal 
Cr.,3 domain but retains the original ability of IgG to 
bind antigen and complement [I] . As contaminant 
traces of plasmin may contribute to the extrinsic 
activation of complement [2], we present here the 
results obtained with a Facb fragment prepared using 
solid phase-bound plasmin for the proteolysis of IgG. 
It appears that immune complexes formed with Facb 
prepared with particulate plasmin are able to bind and 
activate complement in a very similar way to com- 
plexes formed with IgG. 
2. Materials and methods 
IgG was purified from pooled rabbit serum as 
described previously [l] and subsequently treated 
with 2 mM DFP for 30 min at 30°C. 
Abbreviations: Facb, fragment antigen and complement 
binding (this last property is shown when the fragment is 
involved in an immune complex); Fc, C-terminal half of the 
heavy-chain dimer; pFc’, major C-terminal fragment 
released from IgG by pepsin or plasmin digestion; DFP, 
diisopropylphosphofluoridate; ATEE, N-acetyl-L-tyrosine 
ethyl ester; BAEE, N-benzoyl-L-arginine thyl ester; TAME, 
p-toluene sulfonyl-L-arginine methyl ester; SDS, sodium 
dodecyl sulfate; SBTI, soybean trypsin inhibitor. 
The nomenclature of the complement components 
(Cl, Clq, Clr, Cls) follows the W.H.O. recommendations. 
Enzymatic activities are expressed in nanokatals (nkat.) as 
recommended in the Enzyme Nomenclature (1973). 
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Rabbit immunisation, immune complexes between 
ovalbumin and IgG or Facb, SDS polyacrylamide gel 
electrophoresis, cyanogen bromide peptide prepara- 
tion, C-terminal amino acid determination and tryptic 
peptide analysis were carried out as described pre- 
viously [l] . 
CIS was purified according to Sakai and Stroud 
[3] with minor modifications. The 50% hemolysis 
time assay for complement was a modification of the 
technique described by Lachmann 141. 
Double diffusion and single radial immunodiffusion 
in agarose were as described elsewhere [5]. 
The esterase activity of C 1S was measured with 
1.5 mM TAME, 0.9 mM BAEE and 1 .O mM ATEE 
in 50 mM Tris-HCI, pH 7.6, 150 mM NaCl and 2 mM 
EDTA at 25’C as described previously [6,7]. 
2.1. Cl binding assay 
Immune complexes were preformed in the 
presence of 2 mM DFP and kept suspended in 150 mM 
NaCl. Incubation with human serum was carried out 
at pH 7.5 in the presence of 2.5 mM CaClz and 
100 @g/ml SBTI at O’C for various periods. All sub- 
sequent steps were performed at 0-4°C. After centri- 
fugation at 3000 rev/min the resulting precipitate was 
washed twice with 20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM CaCla and 50 to 100 I.cg/ml SBTI. The 
final precipitate was then suspended in the same 
medium and incubated at 30°C for 45 min to com- 
plete Cl activation. After centrifugation, the proteins 
bound to the immune complexes were extracted with 
50 mM Tris-HCl, pH 7.5,250 mM NaCl, 10 mM EDTA 
and 50 pug/ml SBTI. The extracted proteins were 
analyzed by double diffusion, SDS polyacrylamide 
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gel electrophoresis and measurement of the esterase 
activity. 
2.2. heparation of plasmin 
Plasminogen was purified by affinity chromato- 
graphy from pooled human titrated plasma ccording 
to a technique previously described [8] with slight 
modifications. After concentration by ultrafiltration 
and chromatography on Biogel P4, the yield was 40 
to 50 mg protein starting from 500 ml of plasma. A 
further fractionation on a CM-cellulose column led 
to the separation of two allomeric forms of plas- 
minogen as described previously [9] . Plasminogen 
was activated with urokinase (10 min at 2S°C, enzyme 
to substrate ratio l/200). The final yield of plasmin 
was 30 mg protein (specific activity: 33.3 nkat/mg 
protein, measured at 25’C with 1 .O mM BAEE as 
substrate in 50 mM Tris-HCl, pH 8.0). As both 
allomeric forms proteolyse IgG in the same way [lo] , 
the fraction eluted from Biogel P4 was used for all 
studies described here. Plasmin was coupled to 
Sepharose 4B essentially according to Axen et al. [ 1 l] 
with a protein to packed Sepharose ratio of 8 mg/ml. 
2.3. Preparation of Facb 
Rabbit IgG was brought o pH 2.5 with 1 M formic 
acid and incubated for 30 min at 25°C. The fraction 
was then poured onto a slurry of Sepharose-plasmin 
(plasmin to IgG ratio l/2 to I/5) and the pH raised to 
8.0 with 2 M Tris-base. After incubation for 15 mm 
at 25” C, the mixture was rapidly filtered under vacuum 
and the filtrate collected in the presence of SBTI. 
For structural determinations, the incubation 
medium was purified on Sephadex Cl 50 in 6 M urea, 
0.2 M formic acid as described previously [l] . 
For complement binding assays, Facb was purified 
on Sephadex Cl 50 in 15 mM sodium phosphate, 
150 mM NaCI, pH 7.4. 
All protein fractions were preserved by adding 0.1% 
sodium azide. All chemicals were analytical grade. 
3. Results 
3.1. Chemical characterization of Facb 
The cleavage of IgG with plasmin led to a minimal 
yield of about 85% of Facb. A small amount of unsplit 
IgG was detected by SDS-polyacrylamide g l electro- 
phoresis as shown in fig.1. 
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Fig.1. SDS-polyacrylamide gel electrophoresis of a plasmin 
digest of rabbit IgG. Reduced and alkylated sample (10 pg) 
was applied to the gel (5% acrylamide). The run laster 
270 min. The gel was scanned after staining with Coomassie 
blue R250. 
After cyanogen bromide treatment of Facb the 
C-terminal peptide C3 was purified and its structure 
compared with the corresponding peptide prepared 
from IgG in order to locate the split achieved by 
plasmin (fig.2). Following purification on Sephadex 
G150 in urea formic acid, the two C3 peptides were 
submitted to tryptic digestion as described previously 
[l] . High voltage lectrophoresis atpH 1.9 and 3.6 
enabled the discrimination of 14 tryptic peptides in 
C3 purified from IgG and 11 in C3 purified from 
Facb (fig.3). 
The C-terminal analysis of C3 prepared from Facb 
gave with carboxypeptidase B a selective release of 
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Fig.2. Compared structures of IgG and Facb heavy chains. 
The only methionine residues shown are those delimiting the 
CNBr peptide C3 used in the structural characterization of 
Facb. The disulfide bridge between heavy and light chains is 
only suggested. 
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Fig.3. C-terminal part of C3 peptides. (A) IgG C3, (B) Facb 
C3. The residues are numbered from the inter-heavy-chain 
disulfide bond. 
lysine whereas the analysis performed with a mixture 
of carboxypeptidase A and B led to a sequential release 
of lysine and serine corresponding to C-terminal amino 
acids of peptide Tl 1 (fig.3). N-terminal determinations 
on pFc’ are not reported here, as plasmin can be 
responsible for secondary splits in pFc’ which are 
liable to lead to erroneous interpretations. 
The main cleavage achieved by plasmin appears to 
be at a lysine residue located at 110 residues from 
the inter-heavy chain disulfide bond as was found 
previously for Facb prepared with soluble plasmin 
(fig.3). 
3.2. Cl binding and activation by Facb:ovalbumin 
complexes 
and then brought to pH 8.0, without addition of 
plasmin). 
The IgG and Facb fractions were applied to a The esterase activity extracted was found to be a 
Sephadex G150 column to eliminate major aggregates reliable estimate of the Cl bound ai a complex, as 
prior to complex formation. All measurements were illustrated by the good correlation between the 
carried out in parallel on IgG-ovalbumin, Facb- amount of Clq and Cls bound and the ClH esterase 
ovalbumin, and acid-treated IgG-ovalbumin com- activity extracted (fig.4). In the presence of 10 mM 
plexes (in this last case, IgG was submitted to a EDTA, Cl was disrupted and Clq alone was bound 
preliminary incubation at pH 2.5 for 30 min at 25°C to immune complexes. 
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Fig.4. Fixation of Clq and Cls by IgG-ovalbumin complexes 
compared with extracted TAME esterase activity. Immune 
complexes (1.66 to 11.60 mg) were suspended in human 
serum (4.0 ml) and incubated for 45 min at 0°C. After 
centrifugation, Clq and Cls were assayed in the supernatants 
by radial immunodiffusion. The precipitates were treated 
as described in Materials and methods and the extracted 
ClS esterase activity was measured on TAME. 
Table 1 
Comparison of the esterase activity extracted from Facb-ovalbumin, 
IgG-ovalbumin and acid-treated IgG-ovalbumin. 
Identity with Cl? 
Extracts 
Purified 
IgG Acid-treated IgG Facb ClY 
TAME/BAEE 3.83 3.68 3.73 3.86 
ATEE/TAME 0.73 0.72 0.72 0.73 
BAEE/ATEE 0.36 0.38 0.37 0.35 
Immune complexes (8.0 mg) were suspended in human serum (4.0 ml) for 45 min 
at 0°C. Each result represents the ratio of esterase activity towards two different 
substrates. Other conditions as described in Materials and methods. 
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The esterase activity eluted from the three different 
ovalbumin complexes was unambiguously identified as 
CE (table 1). With three different substrates this 
activity appears to behave exactly as purified ClS. Under 
the conditions used. ClT esterase activity did not seem 
to be detected. 
The incubation of Cl still bound to the immune 
complexes for 45 min at 30°C led to the recovery 
of fully activated ClX after extraction and disruption 
of Ci. When this final activation step was omitted, 
the activation level of extracted ClS showed large 
variations between 30% and 80%. 
The analysis of the extracts by double diffusion 
as well as their SDS-polyacrylamide gel electrophoresis 
pattern indicated the almost exclusive presence of 
Clq, Cl7 and CK. The extraction yield of the Cl 
components, based on ClS was approx. 35 to 40%. 
In the case of Facb-ovalbumin complexes, an 
additional binding of plasmin and/or plasminogen 
was detected by double diffusion. The presence of 
SBTI throughout the binding and elution steps 
prevented any interference of plasmin in the esterase 
assay. 
The binding of Cl as a function of the amount of 
immune complexes followed a very similar evolution 
for the three kinds of complexes. Facb-ovalbumin 
complexes appeared to bind 70 to 75% of the Cl 
bound by IgG-ovalbumin complexes (fig.5). 
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Fig.5 Comparison of the Cl?! esterase activity extracted 
from Facb-Ovalbumin and reference immune complexes. 
Immune complexes (1.56 to 9.72 mg) were suspended in 
human serum (4.0 ml) and treated as described in Materials 
and methods. ClS esterase activity was measured on TAME. 
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Fig.6. Fixation of human Cl by Facb-ovalbumin and 
reference immune complexes as a function of the incubation 
time at 0°C. Immune complexes (Facb-ovalbumin: 3.13 mg; 
IgG-ovalbumin: 3.20 mg acid-treated IgC-ovalbumin: 
3.24 mg) were suspended in human serum (4.0 ml), incubated 
for 5 to 60 min at 0°C and centrifuged. The precipitates 
were treated as described in Materials and methods. TAME 
was used to measure ClS esterase activity. 
The kinetics of binding was also very similar for 
the different complexes (fig.6) with a rapid phase 
(about 10 min) followed by a much slower binding. 
This seems to indicate a high affinity of Cl for the 
immune complexes. 
These results were confirmed by the hemolytic 
assay reflecting the level of Cl remaining in the serum 
after fixation by the different immune complexes, 
IgG-ovalbumin, acid-treated IgG-ovalbumin, and 
Facb-ovalbumin gave respectively a relative binding 
of lOO%, 77% and 63%. 
The activation of Cl by Facb-ovalbumin com- 
plexes appeared to be promoted in the same way as 
by the two other ovalbumin complexes. This observa- 
tion was based on the rapid kinetics of activation of 
Cl bound to Facb-ovalbumin complexes upon 
incubation to reach maximal activation of C 1. 
4. Discussion 
These results show that the Facb fragment of IgG 
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can contribute to the study of the binding and activa- 
tion of Cl. They rule out an absolute prerequisite for 
the integrity of the entire Fc for the activation of Cl 
as was postulated previously [ 121. These results 
confirm other preceeding observations on Facb 
prepared with soluble plasmin [ 1 ,131. 
The differences in binding properties observed 
between Facb-ovalbumin complexes and reference 
complexes seem however to show that the C,3 
domain of IgG may also contribute to the binding of 
Cl. This domain may interact with C 1 r as an interac- 
tion between Clr and an IgG-Sepharose system was 
reported previously [ 141. This would strengthen the 
major interaction between Clq and the C,2 domain 
[151- 
The affinity of plasmin for the Facb-ovalbumin 
complexes underlines the absolute requirement for 
particulate plasmin to prepare Facb and for the 
presence of selective inhibitors of plasmin in the 
media used for the study of Cl activation. 
Acknowledgements 
This investigation was supported by research 
grants from the Centre National de la Recherche 
Scientiflque (ERA No. 36) the Delegation G&r&ale 
a la Recherche Scientifique et Technique (Contrat 
No. 75.7.0747) and the Fondation pour la Recherche 
Medicale. 
References 
[l] Colomb, M. G. and Porter, R. R. (1975) Biochem. J. 
145,177-183. 
[2] Cooper, N. (1973) in: Contemporary Topics in 
Molecular Immunology (Reisfeld, R. A., ed.) Vol. 2, 
pp. 155-183, Plenum, New York. 
[ 31 Sakai, K. and Stroud, R. M. (1973) .I. Immun. 110, 
141 
151 
[61 
[71 
181 
[91 
[lOI 
1111 
1121 
[I31 
iI41 
1151 
1010-1020. 
Lachmann, P. J., Hobart, M. J. and Aston, W. P. (1973) 
in: Handbook of Experimental Immunology (Weir, 
D. M., ed.) Vol. 1, pp. S-10, Blackwell, Oxford. 
Ouchterlony, 6. and Nilsson, L. A. (1973) in: Hand- 
book of Experimental Immunology (Weir, D. M., ed.) 
Vol. 1, pp. 19.1-19.39, Blackwell, Oxford. 
Hazen, Cl. G. (1974) in: Methods of Enzymatic Analysis 
(Bergmeyer, H. U., ed.) Vol. 2, pp. 1000-1057, 
Academic Press, New York. 
Valet, G. and Cooper, N. R. (1974) J. Immun. 112, 
339-350. 
Brockway, W. J. and Castellino, F. J. (1972) Arch. 
Biochem. Biophys. 151, 194-199. 
McClintock, D. K., Englert, M. E., Dziobkowski, C., 
Snedeker, E. H. and Bell, P. H. (1974) Biochemistry 13, 
5334-5344. 
Arlaud, G., Meyer, C. and Colomb, M. G. (197.5) 10th 
FEBS Meeting, Paris, Abstract No. 1590. 
Axen, R., Porath, J. and Ernback, S. (1967) Nature 214, 
1302-1304. 
Allan, R. and Isliker, H. (1974) Immunochemistry 11, 
243-248. 
McLennan, I. C. M., Connell, G. E. and Gotch, F. M. 
(1974) Immunology 26, 303-310. 
Assimeh, S. N. and Painter, R. H. (1975) J. Immun. 
115,488-494. 
Kehoe, J. M. and Fougereau, M. (1969) Nature 224, 
1212-1213. 
136 
